Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Acyclovir Suppressive Therapy Following Neonatal HSV CNS Infection
NCT00031460Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 1997
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of aciclovir in herpes simplex virus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 1997; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT00031460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031460.